NOVEL SALT OF THE ABEXINOSTAT, THE CRYSTALLINE FORM ASSOCIATED WITH THEM, THE PROCESS FOR PREPARING THEM AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Abexinostat Tosylate of Formula (II): and its crystalline form I characterized by its powder X-ray diffraction pattern, its Raman spectrum, and its 13C solid state NMR spectrum CP / MAS. pharmaceuticalsTosylate d'abexinostat de formule (II) : et sa forme cristalline I caractérisée par son diagramme de diffraction X sur poudre, son spectre Raman, et son spectre RMN à l'état solide 13C CP/MAS. Médicaments